Serhii Melnyk

Serhii Melnyk is a seasoned professional in clinical development, currently serving as a Senior Clinical Development Manager at ITM Isotope Technologies Munich SE since August 2022. Prior experience includes roles as Clinical Development Manager at MorphoSys from February 2020 to July 2022 and Clinical Trial Manager at Premier Research from April 2014 to January 2020. Serhii Melnyk has also worked as a Senior CRA and Lead CRA at ICON plc and began career in clinical operations as a Clinical Research Associate at PSI CRO AG. Earlier medical experience includes serving as an Oncologist and Radiotherapist at Zina Memorial Lissod Cancer Hospital and as a General Practitioner at Adult Outpatient Clinic #2. Educational qualifications include an MD from Bohomolets National Medical University, obtained between 2000 and 2006.